In a recent paper by Tijms et al. (2024), using mass spectrometry proteomics in human cerebrospinal fluid from 187 controls and 419 AD patients, the authors defined five AD molecular subtypes including a new one related to CP dysfunction. The gene discussed is CP; the disease is Alzheimer disease.